Dr. John Cush RheumNow
4 years 9 months ago
ICYMI: DORIS - Defining Remission in Lupus
Proponents of treat to target in systemic lupus erythematosus (SLE) have all agreed that "remission" should be the goal, but defining remission may be tricky in SLE.
Read on...
https://t.co/hVfzAtRzgY https://t.co/hSPz1eASzF
Dr. John Cush RheumNow
4 years 9 months ago
ICYMI: Giant Cell Arteritis Novel Treatment Options
https://t.co/ywqGZNmHOa https://t.co/2hLESL1RjO
Dr. John Cush RheumNow
4 years 9 months ago
ICYMI: IL-35 (blood and urine) is elevated in #SLE pts with nephritis. Small study of 42 SLE pts serum IL-35 had 90% sensitivity & 65% specificity while urine IL-35 had 86.4% sensitivity and 75% specificity to establish the diagnosis of LN https://t.co/SgmGDSU8dZ
Dr. John Cush RheumNow
4 years 9 months ago
Telemedicine Upside Interview with Dr. Alvin Wells
Dr. Jack Cush interviews telemedicine guru, Dr. Alvin Wells, on the current state of telemedicine and what the future holds for telehealth in rheumatology.
https://t.co/iOpKqjIVuP https://t.co/emseMx4iZ0
Dr. John Cush RheumNow
4 years 9 months ago
Spondyloarthritis Panel Discussion: ACR21 Meeting
Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood discuss abstracts #0562, #1919, #0907, #0364 and #0919
@synovialjoints @doctorRBC @uptoTate @RHEUMarampa @AkhilSoodMD
https://t.co/g0ARcP26wt https://t.co/8Lpwpf6AI1
Dr. John Cush RheumNow
4 years 9 months ago
Watch Now: Can We Stop Medication in Systemic JIA?
https://t.co/yRIb70YVME https://t.co/EJ2PmC6xKY
Dr. John Cush RheumNow
4 years 9 months ago
Third Time's the Charm - COVID Vaccination While on Rituximab
https://t.co/3j0KeQtzw1 https://t.co/YvgpaDX7tv
Dr. John Cush RheumNow
4 years 9 months ago
Rheumatoid arthritis (RA) has been linked to a higher risk of dementia and cognitive dysfunction, but interestingly this association has diminished in the last few decades with aggressive DMARD and targeted therapies.
https://t.co/T1feTkSKQv https://t.co/XElvgsGC0E
A remaining challenge for clinicians is the ability to delay, if not completely stop, structural progression in patients with axSpA, whether they are diagnosed with radiographic (r-axSpa) or non-radiographic (nr-axSpA) disease.
Dr. John Cush RheumNow
4 years 9 months ago
Best of PsA Day 4 - MACE in PsA
https://t.co/NTM1GR7d5W https://t.co/ZxPJ8jDXhD
Dr. John Cush RheumNow
4 years 9 months ago
Watch: Rheumatic Diseases Can Take your Breath Away
https://t.co/7Butbt50N3 https://t.co/4VV1myDXWV
In spite of the transformative growth of telemedicine during the COVID-19 pandemic, rheumatologists use of telemedicine is waning, much like the use of masks. Dr. Jack Cush interviews telemedicine guru, Dr. Alvin Wells, on the current state of telemedicine and what the future holds for telehealth in rheumatology.
